Latest Strategy News

Insignia Financial shareholders met on 13 April 2026 and overwhelmingly backed a $4.80 per share acquisition scheme by CC Capital, valuing the company at about $3.3 billion and offering a near 57% premium to pre-offer prices.

Echelon Resources' Palm Valley Joint Venture has locked in a gas supply agreement with the Northern Territory government, enabling drilling of two new wells to restore production capacity by mid-2026.

MinRex Resources has finalized its merger with Electrum Discovery, creating a well-funded ASX-listed explorer with advanced gold and copper projects in Serbia and Australia. The deal brings Electrum’s Tlamino Gold Project and Timok East Copper-Gold targets into MinRex’s portfolio, alongside its existing Sofala Gold Project in New South Wales.

Power Minerals has completed due diligence on the Morro do Ferro rare earths project in Brazil, revealing exceptional magnetic rare earth oxide grades that underpin plans to finalise acquisition and ramp up exploration.

Centaurus Metals has drawn strong non-binding offers from ten international financiers totaling up to US$320 million to fund its Jaguar Nickel Sulphide Project in Brazil. The company aims to appoint a lead financier by Q3 2026 alongside its Final Investment Decision.

Jameson Resources has secured A$3 million through a discounted share placement to advance critical environmental approvals and Indigenous engagement for its Crown Mountain coal project in British Columbia, aiming to submit the final application by late 2026.

Red Sky Energy has locked in a binding agreement with Santos to drill the Willowie appraisal well in South Australia’s Innamincka Dome, aiming to build on recent production gains and accelerate cashflow.

Pro Medicus has secured a 5-year, A$37 million contract renewal with Northwestern Medicine, featuring higher minimum usage commitments and increased fees per transaction, reflecting growth in exam volumes.

Stavely Minerals has locked in A$4 million through a heavily oversubscribed placement, backing its upcoming Thursday’s Gossan Scoping Study and exploration programs. The raise underscores investor confidence ahead of key milestones.

Prairie Lithium is poised to begin commercial lithium production in Q4 2026 as its Direct Lithium Extraction facility nears completion, backed by a binding offtake agreement covering 100% of Phase 1 output and a strategic AU$10 million equipment contribution from Hydro Lithium.

Argent BioPharma has finalized the acquisition of CannPal Animal Therapeutics, securing a Phase 3 veterinary epilepsy asset with near-term commercial prospects and an option to acquire the Neuvis® drug delivery platform, enhancing its neurological portfolio and U.S. market ambitions.

Freelancer Limited has delivered a landmark FY25 with record profitability, a major NASA contract win, and significant AI-driven growth across its marketplaces and payment services.